NapiFeryn Biotech – Polish startup company who developed and patented unique technology of obtaining rapeseed protein from the side-stream of the oil pressing.
We are truly honored to announce that from 5 March 2019 we have been chosen, as one of a few companies in Poland, to participate in one of the biggest and most prestigious programmes on behalf of the European Commission – Horizon 2020. Thanks to the SME Instrument (Small and Medium-sized Enterprises) we have received the Funding and support in our innovative project ALSEOS – ‘Technology to turn waste from rapeseed oil production into valuable food protein”.
Horizon 2020, H2020-EIC-SMEInst-2018-2020
Project Acronym: ALSEOS
Title: Technology to turn waste from rapeseed oil production into valuable food protein
Project information: Horizon 2020 is one of the biggest and most prestigious programmes on behalf of the European Commission. Thanks to the SME Instrument (Small and Medium-sized Enterprises) we have received the Funding and support in our innovative project.
The continuing growth of world population is pushing demand for food. Climate changes and limited resources for farming lead to increased interest in new sources of nutrients alternative to meat. Additionally, human diet undergoes a significant shift towards proteins. Therefore, the growth of plant protein market is predicted to be drastically driven up in the coming years. Oilseeds, known for their high content of nutritious proteins, are expected to take center stage as main source of plant proteins aimed for human consumption. Nowadays, the main product of rapeseed processing is oil. A by-product – rapeseed cake – is used as animal feed. There is no commercial technology capable of extracting fully functional protein from rapeseed cake. At NapiFeryn BioTech we came up with a new technology which allows more efficient use of this by-product. Our technology is protected with three patent applications. It enables full recovery of high-quality rapeseed cake proteins, ready to be used in food industry. Our business model is based on licensing of the technology to rapeseed processors.
In the Ph2 project we aim primarily at delivering full-scale demonstrator (TRL9) of the rapeseed protein isolation technology at the commercial level (market launch), collect and prove all the data needed to quantify the cost-effectiveness of our technology.
More information: European Commission Horizon H2020 Project website.
NAPIFERYN BIOTECH completes an important technology milestone in the development of the Horizon 2020 funded ALSEOS project
NapiFeryn BioTech concludes the European Commission founded ALSEOS project.
Lodz, 30th January 2023: NapiFeryn BioTech Sp. z o.o. (“NapiFeryn”), creator of unique, patented technology for obtaining rapeseed protein from side-streams of…
Since 2019, NapiFeryn Biotech (NFB) has been involved with the Horizon 2020 (H2020) SME Instrument. The funding and support received…
Together with support from the EU’s Horizon 2020 programme, NFB has been focused on developing and implementing technology-driven processes that…
To live a healthy and well-balanced life, protein is essential to incorporate in our diets. However, with a growing global…
Since 2019, NapiFeryn Biotech has been involved with the Horizon 2020 (H2020) SME Instrument. The funding and support received from…
We are well aware that plant-based products have gained a reputation of being “alternative-protein sources” to that of animal-based products….
Plant-based proteins have long been researched and supported in their efficiency to lead in a more sustainable world. Not only…